1
项与 Docetaxel Liposomal(Azaya Therapeutics) 相关的临床试验A Phase I, Open-label, Dose-escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Intravenously Administered ATI-1123, a Liposomal Docetaxel Formulation, on an Every 3 Week Schedule, in Patients With Advanced Solid Tumors
The purpose of this study is to determine the safety profile, including the maximum tolerated dose (MTD), of ATI-1123 a liposomal formulation of docetaxel, in the treatment of cancer patients with advanced solid tumors.
100 项与 Docetaxel Liposomal(Azaya Therapeutics) 相关的临床结果
100 项与 Docetaxel Liposomal(Azaya Therapeutics) 相关的转化医学
100 项与 Docetaxel Liposomal(Azaya Therapeutics) 相关的专利(医药)
100 项与 Docetaxel Liposomal(Azaya Therapeutics) 相关的药物交易